SCHEMBL21323243

SCHEMBL21323243

O=C(CCc1ccc(C(F)(F)F)cn1)N1CC2CN(C(=O)c3ccc4[nH]nnc4c3)CC2C1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ATXN2 Q99700 3/20 0.41
▸ KDM4E B2RXH2 1/20 0.39
▸ ENPP2 Q13822 1/20 0.37
▸ DGAT2 Q96PD7 1/20 0.37
▸ HCRTR1 O43613 3/20 0.36
▸ HCRTR2 O43614 3/20 0.36
▸ SCN9A Q15858 3/20 0.36
▸ GAA P10253 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ LIPE Q05469 1/20 0.35
▸ MCHR1 Q99705 1/20 0.35
▸ HPGD P15428 1/20 0.34
▸ DAO P14920 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16963021 1.00 ATXN2 (0.41) ATXN2KDM4EENPP2DGAT2HCRTR1
SCHEMBL21323349 0.88 ENPP2 (0.43) ATXN2KDM4EENPP2DGAT2MCHR1
SCHEMBL16962369 0.88 ENPP2 (0.43) ATXN2KDM4EENPP2DGAT2MCHR1
SCHEMBL16963022 0.85 KDM4E (0.38) ATXN2KDM4EENPP2SCN9AGAA
SCHEMBL21323395 0.84 ENPP2 (0.41) ATXN2ENPP2DGAT2
SCHEMBL16963057 0.84 ENPP2 (0.41) ATXN2ENPP2DGAT2
SCHEMBL16963608 0.84 HTR2B (0.38) ATXN2KDM4EALDH1A1HPGD
SCHEMBL21323101 0.83 ATXN2 (0.41) ATXN2ENPP2DGAT2SCN9ADAO
SCHEMBL16963655 0.83 ATXN2 (0.41) ATXN2ENPP2DGAT2SCN9ADAO
SCHEMBL21322907 0.83 ENPP2 (0.39) ATXN2ENPP2DGAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900669-B1 HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND RELATED COMPOUNDS AS AUTOTAXIN (ATX) INHIBITORS AND AS INHIBITORS OF THE LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION FOR TREATING E.G. RENAL DISEASES HOFFMANN LA ROCHE (CH) 2019-09-04 — — EP disclosed
Send feedback